Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05014256 · ClinicalTrials.gov registry record · NA
System Interventions to Achieve Early and Equitable Transplants (STEPS) Study
A NA study of Chronic Kidney Diseases, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 1,168
- Enrollment target
- 1
- Study location
NCT05014256: Completed NA study of Chronic Kidney Diseases, sponsored by Wake Forest University Health Sciences.
NCT05014256 is a NA study of Chronic Kidney Diseases that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1,168 participants, above the 429-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (172% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05014256, a NA study of Chronic Kidney Diseases, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,168 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will study how kidney care for everyone despite race can reduce racial differences in care and improve access to kidney transplants, and specifically living donor kidney transplants (LDKT), for individuals with chronic kidney disease. A study focused on equality and patient needs (called 'STEPS') will 1) create a program to identify people who may need a kidney transplant ('STEPS Surveillance') and find people in health systems who may be able to receive kidney transplants early in their care and (2) study how well the 'STEPS Outreach' program works (comprised of transplant social workers and transplant coordinators who focus on equality and patient needs) compared to usual care to improve access to kidney transplants among Black and non-Black individuals as well as to improve access to transplants for everyone.
Primary Outcome
Number of patients that said "yes" to the completion of transplant evaluation as reported in health system EHR and Administrative reports
Conditions Studied
Interventions
- BEHAVIORAL STEPS Health System Outreach intervention
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,168 participants |
| Start Date | 2022-04-02 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the finished NCT05014256 record still lists
NCT05014256 is an interventional study that assigns participants to a tested intervention. Its 1,168 participants enrollment target places it among the larger protocols in the corpus, above the 429-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (172% higher).
The record links to 1 condition, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which STEPS Health System Outreach intervention is the first listed.
NCT05014256 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05014256 about?
NCT05014256 is a clinical study titled "System Interventions to Achieve Early and Equitable Transplants (STEPS) Study". This project will study how kidney care for everyone despite race can reduce racial differences in care and improve access to kidney transplants, and specifically living donor kidney transplants (LDKT), for individuals with chronic kidney disease. A study focused on equality and patient needs (calle...
What is the current status of trial NCT05014256?
This trial is currently completed. It is a NA study. The enrollment target is 1,168 participants. The study started on 2022-04-02. Estimated completion is 2025-12-31.
What conditions does trial NCT05014256 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases.
What interventions are being tested in trial NCT05014256?
The interventions under investigation include: STEPS Health System Outreach intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05014256?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05014256 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05014256's enrollment target sits among peer trials
1,168 6th of 73 higher than 68 of 73 other Chronic Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Mindfulness in Chronic Kidney Disease
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
RECRUITING · NA
-
Handgrip Exercise Training and CKD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06469788 · 1,170 participants · NA
Testimonials and Navigation in Rheumatology
- NCT07009509 · 1,166 participants · NA
Pilot Study of the YES-CAN! Program to Prevent Youth Nicotine Vaping
- NCT07237048 · 1,164 participants · Phase 2
Minocycline in Stroke Study at Maimonides
- NCT04275557 · 1,174 participants
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI